Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren’s Syndrome patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren’s Syndrome patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-17
DOI
10.1038/s41598-018-29411-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of the ACR-EULAR criteria for primary Sjögren’s syndrome in a Dutch prospective diagnostic cohort
- (2018) Jolien F van Nimwegen et al. RHEUMATOLOGY
- Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome
- (2017) Suresh C. Regmi et al. EXPERIMENTAL EYE RESEARCH
- Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S
- (2017) Michel Theron et al. Frontiers in Immunology
- Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome
- (2016) Zhen Meng et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Lactoferrin-Loaded Contact Lenses
- (2015) Valentina Pastori et al. CORNEA
- Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations
- (2015) Pilar Brito-Zerón et al. Expert Review of Clinical Immunology
- Cystatin C is a disease-associated protein subject to multiple regulation
- (2015) Yuekang Xu et al. IMMUNOLOGY AND CELL BIOLOGY
- Cathepsin S-Dependent Protease-Activated Receptor-2 Activation: A New Mechanism of Endothelial Dysfunction
- (2015) D. J. Nikolic-Paterson JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cysteine cathepsins and extracellular matrix degradation
- (2014) Marko Fonović et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects
- (2014) Christopher D. Payne et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Advances in the understanding and treatment of systemic complications in Sjögrenʼs syndrome
- (2014) Pilar Brito-Zerón et al. CURRENT OPINION IN RHEUMATOLOGY
- Cathepsin S Causes Inflammatory PainviaBiased Agonism of PAR2and TRPV4
- (2014) Peishen Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cathepsin S Signals via PAR2 and Generates a Novel Tethered Ligand Receptor Agonist
- (2014) Sarina B. Elmariah et al. PLoS One
- Tear Cathepsin S as a Candidate Biomarker for Sjögren's Syndrome
- (2014) Sarah F. Hamm-Alvarez et al. Arthritis & Rheumatology
- Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming
- (2013) Khader Valli Rupanagudi et al. ANNALS OF THE RHEUMATIC DISEASES
- A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome
- (2013) Mihir Shah et al. JOURNAL OF CONTROLLED RELEASE
- Post-collection processing of Schirmer strip-collected human tear fluid impacts protein content
- (2012) Aleksandra K. Denisin et al. ANALYST
- Determination of cathepsin S abundance and activity in human plasma and implications for clinical investigation
- (2012) Jennifer M. Cox et al. ANALYTICAL BIOCHEMISTRY
- Accumulation of Secretory Vesicles in the Lacrimal Gland Epithelia Is Related to Non-Sjögren's Type Dry Eye in Visual Display Terminal Users
- (2012) Mizuka Kamoi et al. PLoS One
- Changes in Rab3D expression and distribution in the acini of Sjögren's syndrome patients are associated with loss of cell polarity and secretory dysfunction
- (2011) Verónica Bahamondes et al. ARTHRITIS AND RHEUMATISM
- Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity
- (2011) Mark Baugh et al. JOURNAL OF AUTOIMMUNITY
- Overexpression of Cathepsin S Induces Chronic Atopic Dermatitis in Mice
- (2011) Nari Kim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer
- (2010) Eva Kolwijck et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Tear proteomics in evaporative dry eye disease
- (2010) P Versura et al. EYE
- Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis
- (2010) Dana Haves-Zburof et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland
- (2009) Kaijin Wu et al. EXPERIMENTAL EYE RESEARCH
- Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy
- (2009) Katja Schenke-Layland et al. EXPERIMENTAL EYE RESEARCH
- Cathepsin S Regulates Class II MHC Processing in Human CD4+ HLA-DR+ T Cells
- (2009) C. M. Costantino et al. JOURNAL OF IMMUNOLOGY
- Role of lactoferrin in the tear film
- (2008) J FLANAGAN et al. BIOCHIMIE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started